Some studies have suggested that the status of RF or anti-CCP antibody in RA patients is associated with a clinical response to anti-TNFα treatment [7]–[14], whereas such a correlation was not found in other studies [15]–[19]. This evidence concerns the gene TNF and rheumatoid arthritis.